We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Editorial |  ONLINE FIRST
Maurizio Fava, MD
JAMA Psychiatry. Published online September 30, 2015. doi:10.1001/jamapsychiatry.2015.1727

Viewpoint |  ONLINE FIRST
Patricio O’Donnell, MD, PhD; Michael D. Ehlers, MD, PhD
JAMA Psychiatry. Published online September 30, 2015. doi:10.1001/jamapsychiatry.2015.1735

Special Communication | 
Daniel H. Mathalon, PhD, MD; Vikaas S. Sohal, MD, PhD
JAMA Psychiatry. 2015;72(8):840-844. doi:10.1001/jamapsychiatry.2015.0483.

Original Investigation | 
Maria M. Rive, MD; Roel J. T. Mocking, MSc; Maarten W. J. Koeter, PhD; et al.
JAMA Psychiatry. 2015;72(7):687-696. doi:10.1001/jamapsychiatry.2015.0161.
Includes: Supplemental Content

Invited Commentary | 
Charles F. Reynolds III, MD
JAMA Psychiatry. 2015;72(6):619-620. doi:10.1001/jamapsychiatry.2015.0174.

Original Investigation | 
Madeleine Goodkind, PhD; Simon B. Eickhoff, DrMed; Desmond J. Oathes, PhD; et al.
JAMA Psychiatry. 2015;72(4):305-315. doi:10.1001/jamapsychiatry.2014.2206.
Includes: Supplemental Content

Original Investigation | 
Elaine Setiawan, PhD; Alan A. Wilson, PhD; Romina Mizrahi, MD, PhD; et al.
JAMA Psychiatry. 2015;72(3):268-275. doi:10.1001/jamapsychiatry.2014.2427.
Includes: Supplemental Content

Original Investigation | 
Robert H. Pietrzak, PhD, MPH; Yen Ying Lim, PhD; Alexander Neumeister, MD; et al.
JAMA Psychiatry. 2015;72(3):284-291. doi:10.1001/jamapsychiatry.2014.2476.

Original Investigation | 
Deepak K. Sarpal, MD; Delbert G. Robinson, MD; Todd Lencz, PhD; et al.
JAMA Psychiatry. 2015;72(1):5-13. doi:10.1001/jamapsychiatry.2014.1734.
Includes: CME, Supplemental Content

Original Investigation | 
Andy C. Belden, PhD; Deanna M. Barch, PhD; Timothy J. Oakberg, MA; et al.
JAMA Psychiatry. 2015;72(1):40-48. doi:10.1001/jamapsychiatry.2014.1604.
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Neurology
Original Investigation  | 
Targeting Prodromal Alzheimer Disease With Avagacestat A Randomized Clinical Trial
Vladimir Coric, MD; Stephen Salloway, MD; Christopher H. van Dyck, MD; et al.
JAMA Neurology
Review  | 
Basal Ganglia Circuits as Targets for Neuromodulation in Parkinson Disease
Mahlon R. DeLong, MD; Thomas Wichmann, MD
JAMA Neurology
Review  | 
Naturally Occurring Monoclonal Antibodies and Their Therapeutic Potential for Neurologic Diseases
Bharath Wootla, PhD; Jens O. Watzlawik, PhD; Arthur E. Warrington, PhD; et al.
JAMA Neurology
Editorial  | 
Neurogranin Levels in Cerebrospinal Fluid A New Addition to the Alzheimer Disease Diagnostic Toolbox
Henrik Zetterberg, MD, PhD; Kaj Blennow, MD, PhD